SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
Crossref DOI link: https://doi.org/10.1186/s12933-017-0547-1
Published Online: 2017-05-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zou, Honghong
Zhou, Baoqin
Xu, Gaosi
Funding for this research was provided by:
the National Natural Science Foundation of China (No.H0517/81560132)
